For SMA, SMaRT has been used to incorporate exon 7 in the transcript from the SMN2 gene in SMA patient fibroblasts and in a mouse model of SMA, resulting in increased levels of full-length SMN protein [96–98]. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.